Computational Advances in Drug Safety: Systematic and Mapping Review of Knowledge Engineering Based Approaches

Drug Safety (DS) is a domain with significant public health and social impact. Knowledge Engineering (KE) is the Computer Science discipline elaborating on methods and tools for developing “knowledge-intensive” systems, depending on a conceptual “knowledge” schema and some kind of “reasoning” process. The present systematic and mapping review aims to investigate KE-based approaches employed for DS and highlight the introduced added value as well as trends and possible gaps in the domain. Journal articles published between 2006 and 2017 were retrieved from PubMed/MEDLINE and Web of Science® (873 in total) and filtered based on a comprehensive set of inclusion/exclusion criteria. The 80 finally selected articles were reviewed on full-text, while the mapping process relied on a set of concrete criteria (concerning specific KE and DS core activities, special DS topics, employed data sources, reference ontologies/terminologies, and computational methods, etc.). The analysis results are publicly available as online interactive analytics graphs. The review clearly depicted increased use of KE approaches for DS. The collected data illustrate the use of KE for various DS aspects, such as Adverse Drug Event (ADE) information collection, detection, and assessment. Moreover, the quantified analysis of using KE for the respective DS core activities highlighted room for intensifying research on KE for ADE monitoring, prevention and reporting. Finally, the assessed use of the various data sources for DS special topics demonstrated extensive use of dominant data sources for DS surveillance, i.e., Spontaneous Reporting Systems, but also increasing interest in the use of emerging data sources, e.g., observational healthcare databases, biochemical/genetic databases, and social media. Various exemplar applications were identified with promising results, e.g., improvement in Adverse Drug Reaction (ADR) prediction, detection of drug interactions, and novel ADE profiles related with specific mechanisms of action, etc. Nevertheless, since the reviewed studies mostly concerned proof-of-concept implementations, more intense research is required to increase the maturity level that is necessary for KE approaches to reach routine DS practice. In conclusion, we argue that efficiently addressing DS data analytics and management challenges requires the introduction of high-throughput KE-based methods for effective knowledge discovery and management, resulting ultimately, in the establishment of a continuous learning DS system

Generating Reliable and Responsive Observational Evidence: Reducing Pre-analysis Bias

A growing body of evidence generated from observational data has demonstrated the potential to influence decision-making and improve patient outcomes. For observational evidence to be actionable, however, it must be generated reliably and in a timely manner. Large distributed observational data networks enable research on diverse patient populations at scale and develop new sound methods to improve reproducibility and robustness of real-world evidence. Nevertheless, the problems of generalizability, portability and scalability persist and compound. As analytical methods only partially address bias, reliable observational research (especially in networks) must address the bias at the design stage (i.e., pre-analysis bias) including the strategies for identifying patients of interest and defining comparators. This thesis synthesizes and enumerates a set of challenges to addressing pre-analysis bias in observational studies and presents mixed-methods approaches and informatics solutions for overcoming a number of those obstacles. We develop frameworks, methods and tools for scalable and reliable phenotyping including data source granularity estimation, comprehensive concept set selection, index date specification, and structured data-based patient review for phenotype evaluation. We cover the research on potential bias in the unexposed comparator definition including systematic background rates estimation and interpretation, and definition and evaluation of the unexposed comparator. We propose that the use of standardized approaches and methods as described in this thesis not only improves reliability but also increases responsiveness of observational evidence. To test this hypothesis, we designed and piloted a Data Consult Service - a service that generates new on-demand evidence at the bedside. We demonstrate that it is feasible to generate reliable evidence to address clinicians’ information needs in a robust and timely fashion and provide our analysis of the current limitations and future steps needed to scale such a service

A Systems-Level Approach to Understand The Seasonal Factors Of Early Development With Clinical and Pharmacological Applications

Major developmental defects occur in 100,000 to 200,000 children born each year in the United States of America. 97% of these defects are from unidentified causes. Many fetal outcomes (e.g., developmental defects), result from interactions between genetic and environmental factors. The lifetime effects from prenatal exposures with low impact (e.g., air pollution) are often understudied. Even when these exposures are studied, the focus is often placed on immediate effects of the exposure (e.g., fetal anomalies, miscarriage rates) leaving lifetime effects largely unexplored. This makes prolonged (or lifetime) effects of low-impact exposures an understudied research area. Included in this set of low-impact exposures is seasonal variance at birth. This thesis measures the effects of seasonal variance at birth on lifetime disease risk at both the population-level and molecular-levels. Four aims, comprising this thesis study, were conducted that utilize data from pharmacology, clinical care (Electronic Health Records) and genetics. These aims included: 1.) Development of an Algorithm to Reveal Diseases with a Prenatal/Perinatal Seasonality Component (described in chapter 2); 2.) Investigation of Climate Variables that Affect Lifetime Disease Risk By Altering Environmental Drivers (described in chapters 3 and 4); 3.) Discovery of Genes Involved in Birth Season – Disease Effects (described in chapter 5) and 4.) Investigation of Pharmacological Inhibitors As Phenocopies of the Birth Season – Disease Effect (described in chapters 6 and 7). Knowledge gained from these four areas, through seven distinct studies, establishes that birth season is a causal risk factor in a number of common diseases including cardiovascular diseases

SYSTEMS METHODS FOR ANALYSIS OF HETEROGENEOUS GLIOBLASTOMA DATASETS TOWARDS ELUCIDATION OF INTER-TUMOURAL RESISTANCE PATHWAYS AND NEW THERAPEUTIC TARGETS

In this PhD thesis is described an endeavour to compile litterature about Glioblastoma key molecular mechanisms into a directed network followin Disease Maps standards, analyse its topology and compare results with quantitative analysis of multi-omics datasets in order to investigate Glioblastoma resistance mechanisms. The work also integrated implementation of Data Management good practices and procedures

The Secondary Use of Longitudinal Critical Care Data

Aims To examine the strengths and limitations of a novel United Kingdom (UK) critical care data resource that repurposes routinely collected physiological data for research. Exemplar clinical research studies will be developed to explore the unique longitudinal nature of the resource. Objectives - To evaluate the suitability of the National Institute for Health Research (NIHR) Critical Care theme of the Health Informatics Collaborative (CCHIC) data model as a representation of the Electronic Health Record (EHR) for secondary research use. - To conduct a data quality evaluation of data stored within the CC-HIC research database. - To use the CC-HIC research database to conduct two clinical research studies that make use of the longitudinal data supported by the CC-HIC: - The association between cumulative exposure to excess oxygen and outcomes in the critically ill. - The association between different morphologies of longitudinal physiology—in particular organ dysfunction—and outcomes in sepsis. The CC-HIC The EHR is now routinely used for the delivery of patient care throughout the United Kingdom (UK). This has presented the opportunity to learn from a large volume of routinely collected data. The CC-HIC data model represents 255 distinct clinical concepts including demographics, outcomes and granular longitudinal physiology. This model is used to harmonise EHR data of 12 contributing Intensive Care Units (ICUs). This thesis evaluates the suitability of the CC-HIC data model in this role and the quality of data within. While representing an important first step in this field, the CC-HIC data model lacks the necessary normalisation and semantic expressivity to excel in this role. The quality of the CC-HIC research database was variable between contributing sites. High levels of missing data, missing meta-data, non-standardised units and temporal drop out of submitted data are amongst the most challenging features to tackle. It is the principal finding of this thesis that the CC-HIC should transition towards implementing internationally agreed standards for interoperability. Exemplar Clinical Studies Two exemplar studies are presented, each designed to make use of the longitudinal data made available by the CC-HIC and address domains that are both contemporaneous and of importance to the critical care community. Exposure to Excess Oxygen Longitudinal data from the CC-HIC cohort were used to explore the association between the cumulative exposure to excess oxygen and outcomes in the critically ill. A small (likely less than 1% absolute risk reduction) dose-independent association was found between exposure to excess oxygen and mortality. The lack of dosedependency challenges a causal interpretation of these findings. Physiological Morphologies in Sepsis The joint modelling paradigm was applied to explore the different longitudinal profiles of organ failure in sepsis, while accounting for informative censoring from patient death. The rate of change of organ failure was found to play a more significan't role in outcomes than the absolute value of organ failure at a given moment. This has important implications for how the critical care community views the evolution of physiology in sepsis. DECOVID The Decoding COVID-19 (DECOVID) project is presented as future work. DECOVID is a collaborative data sharing project that pools clinical data from two large NHS trusts in England. Many of the lessons learnt from the prior work with the CC-HIC fed into the development of the DECOVID data model and its quality evaluation

The Role of Signal Detection in Pharmacovigilance

The World Health Organisation defines pharmacovigilance as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems. Signal detection is a core pharmacovigilance activity. The motivation behind exploring signal detection and evaluation process is the timely detection of safety issues, and ultimately a better protection of public health. This thesis aimed to explore the processes of signal detection and evaluation and to inform regulatory decision making by providing evidence-based solutions to some of the existing questions. We investigated methods of detection and alternative data sources. Furthermore, we were interested to find out which characteristics of drugs make them more prone to have safety issues discovered post-marketing and tried to find predictive characteristics and we tried to gain some insight in the prioritisation process. The current work is relevant for all involved stakeholders, as European Medicines Agency (EMA), national regulatory authorities, pharmaceutical industry and, healthcare professionals and researchers